San Francisco, California
London, United Kingdom
European Pharmacovigilance and clinical trials conference 2016 will provide an opportunity to all its attendees to discuss, share and stay updated with present state of affairs in Pharmacovigilance and clinical trials. It will also allow all its participants to discuss the various developments, challenges faced and innovations in the field. The conference will attempt to explore the reforms required to enhance drug safety and public health. The conference will also provide all its participants an opportunity to network with various pharmaceutical industries; clinical research organizations and PV service providers.
The recent developments in the UK (BREXIT referendum) have raised a lot of questions and panic within all major sectors, and pharma industry is no exception. Though the full impact of these developments on pharma industry is difficult to visualize, but the complexities and the consequences involved need to be understood to ensure drug safety and quality. Hence it is demanding for all to keep them abreast with the latest in the field.
It gives us a great pleasure welcoming you to the European Pharmacovigilance and Clinical Trials 2016 conference.
Key Highlights of the conference:
- Harmonization and Pharmacovigilance
- PV regulations and challenges
- The new EU legislation on clinical trials, its impact and future
- Risk management and minimization
- Adverse drug reactions reporting
- Signal detection and post-authorization safety
- Business development and models in clinical trials
- Clinical data management
- Good Clinical Practices and Good Pharmacovigilance practices
- IT and new technologies for improvement of PV and clinical research
- Strategies to improve clinical trials and PV
- Implications of BREXIT
Our Prominent Speakers include:
Karen Cheng Heil, Safety Medical Director, AstraZeneca
Shelagh Anderson, Vice President of Global Regulatory Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson
Ana-ClaudiaIanos, Director - Safety Risk Lead, Pfizer
Emanuel Lohrmann, Lead Safety Physician, Boehringer Ingelheim
Heike Schoepper, Head Global Drug Safety, Merck Serono
Kashif Sheikh, Senior Safety Surveillance Advisor, Novo Nordisk
Alexandra Ionel, Chief Scientific Officer & DRA Head, Novartis Pharma
Julia Appelskog, QPPV, Head of Pharmacovigilance, Bluefish Pharmaceuticals
Sandy Eisen, Chief Medical Officer, Frontline Pharma Consulting
Jonathan Seltzer, President, ACI Clinical
Anne Gramkow, Head of Safety and QPPV, Pharmacosmos
Leo Ayerakwa, Consultant, European Regulatory Solutions
Nawab Qizilbash, Head & Honorary Senior Lecturer in Pharmacoepidemiology, OXON Epidemiology
Simon Ingate, Principal Consultant - SafetyGauge Product Manager, Pope Woodhead & Associates
Rachel Spokes, Vice President of Pharmacovigilance, EmasPharma
and many more...
Visit www.corvusglobalevents.com to know more about this event
Conference Sponsor & Exhibition Stall
Should you wish to Sponsor, Speak or exhibit in our event, Please feel free to email your interest and queries to: firstname.lastname@example.org
When & Where
Corvus Global Events
Corvus Global Events (CGE) delivers comprehensive insights into the vast series of business topics and strategies through its signature conferences. Our conferences help you to conceptualize, motivate and inspire you to attain your vision. We deliver high-quality, professional and ethical conferences, which are well attended and supported by delegates, speakers, sponsors, exhibitors and media partners.